First Time Loading...

Medincell SA
PAR:MEDCL

Watchlist Manager
Medincell SA Logo
Medincell SA
PAR:MEDCL
Watchlist
Price: 15.2 EUR 1.33% Market Closed
Updated: May 15, 2024

Wall Street
Price Targets

MEDCL Price Targets Summary
Medincell SA

Wall Street analysts forecast MEDCL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDCL is 17.69 EUR with a low forecast of 14.14 EUR and a high forecast of 23.1 EUR.

Lowest
Price Target
14.14 EUR
7% Downside
Average
Price Target
17.69 EUR
16% Upside
Highest
Price Target
23.1 EUR
52% Upside
Medincell SA Competitors:
Price Targets
RHONEMA
Rhone Ma Holdings Bhd
14% Upside
102940
Kolon Life Science Inc
495% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
1% Downside
JAGX
Jaguar Health Inc
123% Upside
600812
North China Pharmaceutical Co Ltd
136% Upside
AMIORG
Ami Organics Ltd
23% Upside
DRREDDY
Dr Reddy's Laboratories Ltd
3% Upside
600216
Zhejiang Medicine Co Ltd
27% Upside

Revenue
Forecast

Revenue Estimate
Medincell SA

For the last 4 years the compound annual growth rate for Medincell SA's revenue is 62%. The projected CAGR for the next 4 years is 84%.

62%
Past Growth
84%
Estimated Growth
Estimates Accuracy
-54%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Medincell SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
22%
Average Beat

Net Income
Forecast

Net Income Estimate
Medincell SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MEDCL's stock price target?
Price Target
17.69 EUR

According to Wall Street analysts, the average 1-year price target for MEDCL is 17.69 EUR with a low forecast of 14.14 EUR and a high forecast of 23.1 EUR.

What is Medincell SA's Revenue forecast?
Projected CAGR
84%

For the last 4 years the compound annual growth rate for Medincell SA's revenue is 62%. The projected CAGR for the next 4 years is 84%.